New study aims to uncover why COVID-19 harms organs months later
NCT ID NCT06608849
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study follows 345 adults to learn how COVID-19 may cause lasting damage to the lungs, heart, and kidneys. Researchers will compare people who had COVID-19 with those who did not, using blood tests, breathing tests, and heart scans. The goal is to find early warning signs and create guidelines to prevent long-term health problems.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better tools for predicting and preventing long-term organ damage after COVID-19.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
10th Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest Diseases
RECRUITINGAthens, Greece
-
1st Department of Internal Medicine, Thriasio General Hospital of Elefsina
RECRUITINGElefsina, Greece
-
2nd Department of Internal Medicine, Thriasio General Hospital of Elefsina
RECRUITINGElefsina, Greece
-
4th Department of Internal Medicine, ATTIKON University General Hospital
RECRUITINGAthens, Greece
-
Obstructive Diseases Clinic, Sotiria Athens Hospital of Chest Diseases
RECRUITINGAthens, Greece
-
Out-patient department of Infectious Diseases, Sotiria Athens Hospital of Chest Diseases
RECRUITINGAthens, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?